| J3111 | Injection, romosozumab-aqqg, 1 mg | 37,590 | $10 | $300.7K |
| J0897 | Injection, denosumab, 1 mg | 10,740 | $20 | $193.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 910 | $50 | $48.2K |
| J7327 | Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 60 | $560 | $33.3K |
| 20611 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa, typically the shoulder, hip, knee, or subacromial bursa, and then uses the syringe… | 250 | $60 | $14.9K |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 20 | $400 | $9.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 120 | $60 | $7.3K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 120 | $60 | $7.1K |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 480 | $10 | $6.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $70 | $3.8K |